📰 Bio Path News
Page 5 - Bio Path News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Path. Real-time updates on events, politics, business and more.
May 4, 2023
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Price Performance NASDAQ:BPTH opened at $1.42 […]
May 3, 2023
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Sunday. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Down 2.8 % Shares of BPTH opened at […]
May 2, 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 83,600 shares, a growth of 10.0% from the March 31st total of 76,000 shares. Based on an average daily volume of 35,400 shares, the days-to-cover ratio is […]
April 26, 2023
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research report sent to investors on Saturday. The firm issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Price Performance NASDAQ BPTH opened at […]
April 25, 2023
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a report released on Saturday. The firm issued a sell rating on the stock. Separately, Roth Capital reissued a buy rating on shares of Bio-Path in a research note on Friday, March 17th. Bio-Path Price Performance NASDAQ BPTH opened at $1.38 on Friday. […]
April 18, 2023
StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a report issued on Friday morning. The brokerage issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Price Performance Shares of Bio-Path stock opened at $1.39 […]
April 10, 2023
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note released on Thursday. The firm issued a sell rating on the stock. Separately, Roth Capital reaffirmed a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Performance Shares of NASDAQ BPTH opened at $1.42 […]
April 9, 2023
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note published on Thursday. The firm issued a sell rating on the stock. Separately, Roth Capital reiterated a buy rating on shares of Bio-Path in a research report on Friday, March 17th. Bio-Path Price Performance BPTH stock opened at $1.42 on […]
April 1, 2023
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Rating) in a research note issued to investors on Wednesday. The firm issued a sell rating on the stock. Separately, Roth Capital restated a buy rating on shares of Bio-Path in a report on Friday, March 17th. Bio-Path Stock Down 18.7 % NASDAQ:BPTH opened at […]
April 1, 2023
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Rating) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 64,100 shares, a drop of 9.7% from the February 28th total of 71,000 shares. Based on an average trading volume of 38,000 shares, the days-to-cover ratio is […]